In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-21 of 21 for your search:
Cancer Type/Condition:  Colon cancer
Trial Type:  Treatment
Treatment/Intervention:  antiangiogenesis therapy
Trial Status:  Active
Trial Phase:  Phase III
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and over
Sponsor: Other
Protocol IDs: CR01/18/10, NCT01189903
2.

Phase: Phase III, Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 75
Sponsor: Other
Protocol IDs: EORTC-1207, 2012-002317-18, NCT01646554
3.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: HEPATICA, NCT00394992
4.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: FIRE-3, NCT00433927
5.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000549541, USCTU-4351, USCTU-EPOC, EUDRACT-2006-003121-82, ISRCTN22944367, EU-20732, EPOC, NCT00482222
6.

Phase: Phase III
Type: Treatment
Status: Active
Age: 20 to 79
Sponsor: Other
Protocol IDs: ICOG-CC01, NCT00497107
7.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2007-000354-31, NCT00646607
8.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: CDR0000598567, GONO-BEBYP-ASL607LIOM03, GONO-AIFA - FARM5C4FB4, EUDRACT:2007-002886-11, GONO– ASL607LIOM03, EU-20860, NCT00720512
9.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: CDR0000598582, GONO-TRIBE, ASL608LIOM04, EUDRACT:2008-001537-10, TRIBE, EU-20859, NCT00719797
10.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: SICOG-0803, SICOG 0803, MARTHA, EudraCT-2008-004890-17, NCT00797485
11.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20080259, NCT00911170
12.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ML 25359, NCT01229813
13.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: ML22011, NCT01249638
14.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 70 and over
Sponsor: NCI
Protocol IDs: NCCTG-N0949, N0949, NCT01279681
15.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: CPP-450, 2010-019140-39, NCT01317433
16.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AFLIBC06097, 2011-005724-17, U1111-1125-8949, NCT01571284
17.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 15808, NCT01584830
18.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CAIRO4, NCT01606098
19.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 70
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: TTD-12-01, 2012-000846-37, NCT01640405
20.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AFLIBL06266, 2012-000048-89, U1111-1128-9325, NCT01670721
21.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EFC11338, U1111-1115-7227, NCT01661270
New Search